(Q35176993)

English

Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

rheumatoid arthritis

0 references

author name string

Alicia Santos Savio

1

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ana Cecilia Machado Diaz

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Araceli Chico Capote

3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Jamilet Miranda Navarro

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Yunier Rodríguez Alvarez

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ricardo Bringas Pérez

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Miguel Estévez del Toro

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Gerardo E Guillen Nieto

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

12 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

BMC Musculoskeletal Disorders

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

copyright license

Creative Commons Attribution 4.0 International

12 March 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Serum interleukin-15 levels are associated with severity of pain in patients with knee osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Proinflammatory soluble interleukin-15 receptor alpha is increased in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Cytokines in the pathogenesis of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

The benefit/risk profile of TNF-blocking agents: findings of a consensus panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Reverse signaling through membrane-bound interleukin-15.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Comparison of the efficacy of the tumour necrosis factor blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Interindividual and intra-articular variation of proinflammatory cytokines in patients with rheumatoid arthritis: potential implications for treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Circadian rhythm of serum interleukin-6 in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Synovial fluid concentration of five different cytokines in rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

28 July 2018

Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Interleukin-15 stimulates macrophages to activate CD4+ T cells: a role in the pathogenesis of rheumatoid arthritis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

IL-15 exacerbates collagen-induced arthritis with an enhanced CD4+ T cell response to produce IL-17.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

Role of cytokines in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4359511

27 September 2018

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1186%2FS12891-015-0516-3

21 January 2018

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1186%2FS12891-015-0516-3

21 January 2018

The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine production by synovial T cells in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25879761

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12891-015-0516-3

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35176993&oldid=2197318634"